{
  "id": 1554,
  "text": "Future large trials are therefore required to demonstrate its efficacy, toxicities and quality of life.# 13.4 Guidelines # 13.4.1 Stage T1b2/T2a2 and negative lymph nodes on radiological staging Treatment strategy should aim for avoiding the combination of radical surgery and postoperative external radiotherapy because of the significant increase in morbidity and no evident impact on survival.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Future large trials are therefore required to demonstrate its efficacy, toxicities and quality of life.# 13.4 Guidelines # 13.4.1 Stage T1b2/T2a2 and negative lymph nodes on radiological staging Treatment strategy should aim for avoiding the combination of radical surgery and postoperative external radiotherapy because of the significant increase in morbidity and no evident impact on survival.\n\n<question>: ",
  "ChatGPT_response_0": "在T1b2/T2a2期和放射学分期阴性淋巴结的情况下，治疗策略应避免联合进行根治性手术和术后外放射治疗。研究表明这种联合治疗并不能明显影响患者的生存率，却会显著增加患者的发病率。因此，未来需要进行更多大规模试验来证明其疗效、毒副作用和对生活质量的影响。根据目前的指南，针对这类病例的治疗策略应该在避免这种联合治疗的前提下，综合考虑患者的具体情况，选择更适合的个体化治疗方案。",
  "query": "未来需要进行大规模试验来证明其疗效、毒副作用和生活质量。在T1b2/T2a2期和放射学分期阴性淋巴结的情况下，治疗策略应该怎么样？避免联合进行根治性手术和术后外放射治疗，因为这会显著增加发病率并且对生存率没有明显影响。",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 未来需要进行大规模试验来证明其疗效、毒副作用和生活质量。在T1b2/T2a2期和放射学分期阴性淋巴结的情况下，治疗策略应该怎么样？避免联合进行根治性手术和术后外放射治疗，因为这会显著增加发病率并且对生存率没有明显影响。\n\n<reference text>: Future large trials are therefore required to demonstrate its efficacy, toxicities and quality of life.# 13.4 Guidelines # 13.4.1 Stage T1b2/T2a2 and negative lymph nodes on radiological staging Treatment strategy should aim for avoiding the combination of radical surgery and postoperative external radiotherapy because of the significant increase in morbidity and no evident impact on survival.\n\n<reply>: ",
  "response": "在T1b2/T2a2期和放射学分期阴性淋巴结的情况下，治疗策略应避免联合进行根治性手术和术后外放射治疗。研究表明这种联合治疗并不能明显影响患者的生存率，却会显著增加患者的发病率。因此，未来需要进行更多大规模试验来证明其疗效、毒副作用和对生活质量的影响。根据目前的指南，针对这类病例的治疗策略应该在避免这种联合治疗的前提下，综合考虑患者的具体情况，选择更适合的个体化治疗方案。"
}